Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electroencephalography | 73 | 2023 | 6314 | 2.480 |
Why?
|
Epilepsy | 41 | 2023 | 3327 | 1.560 |
Why?
|
Epilepsies, Partial | 15 | 2008 | 435 | 1.150 |
Why?
|
Monitoring, Ambulatory | 5 | 2021 | 358 | 0.980 |
Why?
|
Epilepsy, Temporal Lobe | 17 | 2012 | 390 | 0.960 |
Why?
|
Status Epilepticus | 7 | 2011 | 463 | 0.960 |
Why?
|
Electrodes | 9 | 2020 | 617 | 0.850 |
Why?
|
Electrophysiological Phenomena | 3 | 2021 | 309 | 0.690 |
Why?
|
Biophysical Phenomena | 1 | 2020 | 320 | 0.670 |
Why?
|
Anticonvulsants | 17 | 2022 | 1923 | 0.660 |
Why?
|
Cerebral Cortex | 17 | 2021 | 5812 | 0.590 |
Why?
|
Telemetry | 4 | 2006 | 200 | 0.580 |
Why?
|
Diagnosis, Computer-Assisted | 4 | 2011 | 709 | 0.580 |
Why?
|
Temporal Lobe | 10 | 2012 | 1726 | 0.510 |
Why?
|
Artifacts | 5 | 2011 | 1926 | 0.450 |
Why?
|
Evoked Potentials, Visual | 6 | 2015 | 418 | 0.420 |
Why?
|
Monitoring, Physiologic | 9 | 2004 | 1798 | 0.380 |
Why?
|
Signal Processing, Computer-Assisted | 6 | 2015 | 1489 | 0.370 |
Why?
|
Brain Mapping | 13 | 2020 | 6685 | 0.360 |
Why?
|
Brain Diseases | 4 | 2011 | 1554 | 0.350 |
Why?
|
Brain | 23 | 2018 | 27360 | 0.350 |
Why?
|
Convulsants | 3 | 2000 | 70 | 0.350 |
Why?
|
Phenytoin | 6 | 2022 | 189 | 0.320 |
Why?
|
Theta Rhythm | 4 | 2018 | 222 | 0.320 |
Why?
|
Seizures | 12 | 2018 | 2998 | 0.290 |
Why?
|
Sexual Dysfunction, Physiological | 5 | 2010 | 364 | 0.290 |
Why?
|
Epilepsy, Generalized | 2 | 2000 | 181 | 0.280 |
Why?
|
Critical Care | 2 | 2011 | 2715 | 0.280 |
Why?
|
Galactosemias | 2 | 2020 | 126 | 0.250 |
Why?
|
Electrodes, Implanted | 9 | 2016 | 836 | 0.240 |
Why?
|
Intelligence Tests | 2 | 2022 | 504 | 0.240 |
Why?
|
Computer Systems | 2 | 2003 | 469 | 0.240 |
Why?
|
Neurons | 13 | 2021 | 9514 | 0.230 |
Why?
|
Gonadotropins, Pituitary | 1 | 2003 | 70 | 0.220 |
Why?
|
Flurothyl | 3 | 2000 | 10 | 0.220 |
Why?
|
Physicians | 2 | 2021 | 4598 | 0.210 |
Why?
|
Echo-Planar Imaging | 3 | 1999 | 648 | 0.210 |
Why?
|
Semantics | 3 | 2015 | 618 | 0.210 |
Why?
|
Gonadal Steroid Hormones | 2 | 2005 | 707 | 0.210 |
Why?
|
Aspartame | 2 | 2002 | 19 | 0.210 |
Why?
|
Menstruation Disturbances | 2 | 2003 | 143 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-fos | 3 | 2000 | 580 | 0.200 |
Why?
|
Scalp | 2 | 2012 | 391 | 0.200 |
Why?
|
Reading | 2 | 2003 | 543 | 0.190 |
Why?
|
Adult | 82 | 2023 | 223646 | 0.180 |
Why?
|
Panic Disorder | 2 | 1995 | 613 | 0.180 |
Why?
|
N-Glycosyl Hydrolases | 1 | 2000 | 68 | 0.180 |
Why?
|
Acetylcholinesterase | 1 | 2000 | 151 | 0.180 |
Why?
|
Neurology | 2 | 2022 | 786 | 0.180 |
Why?
|
Immunotoxins | 1 | 2000 | 175 | 0.170 |
Why?
|
Humans | 117 | 2023 | 768166 | 0.160 |
Why?
|
Delta Rhythm | 2 | 2018 | 81 | 0.160 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2003 | 702 | 0.160 |
Why?
|
Event-Related Potentials, P300 | 1 | 2000 | 149 | 0.160 |
Why?
|
Magnetoencephalography | 3 | 2006 | 641 | 0.160 |
Why?
|
Epilepsy, Complex Partial | 4 | 2006 | 59 | 0.150 |
Why?
|
Prosencephalon | 1 | 2000 | 305 | 0.150 |
Why?
|
Agraphia | 1 | 1998 | 8 | 0.150 |
Why?
|
Neurites | 1 | 2020 | 389 | 0.150 |
Why?
|
Brain Waves | 2 | 2013 | 417 | 0.150 |
Why?
|
Intelligence | 1 | 2003 | 926 | 0.150 |
Why?
|
Entorhinal Cortex | 3 | 2010 | 287 | 0.150 |
Why?
|
Plant Proteins | 1 | 2000 | 376 | 0.150 |
Why?
|
Microelectrodes | 7 | 2021 | 305 | 0.150 |
Why?
|
Self Care | 5 | 2008 | 799 | 0.150 |
Why?
|
Evoked Potentials | 6 | 2011 | 1058 | 0.140 |
Why?
|
Male | 69 | 2023 | 364719 | 0.140 |
Why?
|
Oxygen | 3 | 2000 | 4270 | 0.140 |
Why?
|
Mental Recall | 3 | 2010 | 1226 | 0.140 |
Why?
|
Auditory Pathways | 1 | 1999 | 238 | 0.140 |
Why?
|
Behavior | 2 | 2002 | 542 | 0.130 |
Why?
|
Mental Processes | 2 | 2009 | 246 | 0.130 |
Why?
|
Pattern Recognition, Visual | 3 | 1997 | 826 | 0.130 |
Why?
|
Female | 62 | 2022 | 397192 | 0.130 |
Why?
|
Frontal Lobe | 5 | 2009 | 1426 | 0.130 |
Why?
|
Middle Aged | 47 | 2021 | 223492 | 0.130 |
Why?
|
Memory Disorders | 3 | 2010 | 1200 | 0.120 |
Why?
|
Cerebral Veins | 1 | 2016 | 157 | 0.120 |
Why?
|
Nervous System | 1 | 1998 | 544 | 0.120 |
Why?
|
Hypogonadism | 4 | 2010 | 805 | 0.120 |
Why?
|
Reaction Time | 2 | 2006 | 2101 | 0.120 |
Why?
|
Carbamazepine | 6 | 2022 | 224 | 0.120 |
Why?
|
Analysis of Variance | 6 | 2009 | 6229 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 20 | 2021 | 36743 | 0.110 |
Why?
|
Brain Stem | 1 | 1999 | 859 | 0.110 |
Why?
|
Adolescent | 27 | 2021 | 89169 | 0.110 |
Why?
|
Information Theory | 1 | 2013 | 49 | 0.110 |
Why?
|
Hippocampus | 5 | 2010 | 3785 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2020 | 1542 | 0.100 |
Why?
|
Neurosurgical Procedures | 2 | 2016 | 2076 | 0.100 |
Why?
|
Testosterone | 7 | 2010 | 2491 | 0.100 |
Why?
|
Triazines | 4 | 2006 | 311 | 0.100 |
Why?
|
Algorithms | 3 | 2011 | 14164 | 0.100 |
Why?
|
Coma | 2 | 2011 | 485 | 0.090 |
Why?
|
Luteinizing Hormone | 7 | 2005 | 822 | 0.090 |
Why?
|
Young Adult | 12 | 2021 | 60066 | 0.090 |
Why?
|
Predictive Value of Tests | 6 | 2012 | 15454 | 0.090 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 13014 | 0.090 |
Why?
|
Estradiol | 5 | 2006 | 1951 | 0.090 |
Why?
|
Quality of Life | 1 | 2012 | 13490 | 0.090 |
Why?
|
Dominance, Cerebral | 5 | 2006 | 623 | 0.090 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2020 | 2815 | 0.090 |
Why?
|
Functional Laterality | 5 | 2010 | 2264 | 0.090 |
Why?
|
Thalamus | 1 | 2016 | 1047 | 0.090 |
Why?
|
Kluver-Bucy Syndrome | 1 | 2009 | 9 | 0.080 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2005 | 553 | 0.080 |
Why?
|
Memory | 2 | 2010 | 2208 | 0.080 |
Why?
|
Melatonin | 1 | 1995 | 670 | 0.080 |
Why?
|
Amygdala | 2 | 1997 | 1380 | 0.080 |
Why?
|
Periodicity | 2 | 2010 | 348 | 0.080 |
Why?
|
Cognition | 4 | 2011 | 7073 | 0.080 |
Why?
|
Electric Stimulation | 3 | 2021 | 1741 | 0.080 |
Why?
|
Linguistics | 1 | 2009 | 110 | 0.080 |
Why?
|
Drug Therapy, Combination | 3 | 2010 | 6316 | 0.080 |
Why?
|
Sphenoid Bone | 2 | 2003 | 176 | 0.080 |
Why?
|
Aged | 21 | 2016 | 171504 | 0.080 |
Why?
|
Computers | 1 | 1991 | 592 | 0.080 |
Why?
|
Sleep | 3 | 2018 | 4819 | 0.080 |
Why?
|
Reference Values | 5 | 2000 | 4938 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2665 | 0.080 |
Why?
|
Computer Terminals | 1 | 2008 | 41 | 0.080 |
Why?
|
Head | 3 | 2010 | 926 | 0.080 |
Why?
|
Reproducibility of Results | 6 | 2023 | 20227 | 0.070 |
Why?
|
Nursing Assessment | 2 | 2008 | 107 | 0.070 |
Why?
|
Self Efficacy | 3 | 2006 | 643 | 0.070 |
Why?
|
Sensitivity and Specificity | 5 | 2008 | 14729 | 0.070 |
Why?
|
Risk Assessment | 1 | 2008 | 24315 | 0.070 |
Why?
|
Time Factors | 12 | 2010 | 40218 | 0.070 |
Why?
|
Visual Perception | 1 | 2015 | 1402 | 0.070 |
Why?
|
Psychology | 1 | 2008 | 353 | 0.070 |
Why?
|
Aged, 80 and over | 8 | 2013 | 59629 | 0.070 |
Why?
|
Malformations of Cortical Development | 1 | 2008 | 176 | 0.070 |
Why?
|
Language | 2 | 2020 | 1557 | 0.070 |
Why?
|
Transcranial Magnetic Stimulation | 3 | 2009 | 1490 | 0.070 |
Why?
|
Video Recording | 2 | 2023 | 976 | 0.060 |
Why?
|
Psycholinguistics | 1 | 2006 | 81 | 0.060 |
Why?
|
Aromatase Inhibitors | 1 | 2010 | 519 | 0.060 |
Why?
|
Migraine Disorders | 1 | 1998 | 1713 | 0.060 |
Why?
|
Anterior Temporal Lobectomy | 1 | 2005 | 46 | 0.060 |
Why?
|
Vagus Nerve Stimulation | 1 | 2008 | 228 | 0.060 |
Why?
|
Preoperative Care | 2 | 2006 | 2258 | 0.060 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2009 | 1140 | 0.060 |
Why?
|
Speech | 1 | 2009 | 557 | 0.060 |
Why?
|
Paraneoplastic Syndromes | 2 | 1997 | 154 | 0.060 |
Why?
|
Nitriles | 1 | 2010 | 980 | 0.060 |
Why?
|
Models, Psychological | 2 | 2008 | 825 | 0.060 |
Why?
|
Triazoles | 1 | 2010 | 904 | 0.060 |
Why?
|
Neuropsychological Tests | 6 | 2020 | 7140 | 0.060 |
Why?
|
Patient Compliance | 2 | 2005 | 2697 | 0.060 |
Why?
|
Membrane Potentials | 1 | 2007 | 1090 | 0.060 |
Why?
|
Technology Assessment, Biomedical | 1 | 2006 | 312 | 0.050 |
Why?
|
Hemianopsia | 1 | 2005 | 121 | 0.050 |
Why?
|
Verbal Learning | 1 | 2006 | 465 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4063 | 0.050 |
Why?
|
Polypharmacy | 1 | 2005 | 307 | 0.050 |
Why?
|
Action Potentials | 1 | 2010 | 1838 | 0.050 |
Why?
|
Anisotropy | 2 | 2020 | 1292 | 0.050 |
Why?
|
Internship and Residency | 1 | 2022 | 5953 | 0.050 |
Why?
|
Electromagnetic Fields | 1 | 2004 | 289 | 0.050 |
Why?
|
Psychomotor Performance | 3 | 2009 | 1892 | 0.050 |
Why?
|
Occipital Lobe | 1 | 2003 | 376 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 4 | 2000 | 8128 | 0.050 |
Why?
|
Prognosis | 3 | 2011 | 30010 | 0.050 |
Why?
|
Wavelet Analysis | 1 | 2021 | 56 | 0.050 |
Why?
|
Evaluation Studies as Topic | 1 | 2004 | 1627 | 0.050 |
Why?
|
Steroids | 1 | 2006 | 938 | 0.050 |
Why?
|
Sex Chromosome Aberrations | 1 | 2001 | 116 | 0.050 |
Why?
|
Age Factors | 5 | 2010 | 18412 | 0.050 |
Why?
|
Face | 2 | 1997 | 1029 | 0.050 |
Why?
|
Stereotyping | 1 | 2003 | 241 | 0.050 |
Why?
|
Phenobarbital | 1 | 2022 | 192 | 0.050 |
Why?
|
Ribosome Inactivating Proteins, Type 1 | 1 | 2000 | 28 | 0.050 |
Why?
|
Models, Anatomic | 2 | 2001 | 680 | 0.050 |
Why?
|
Competency-Based Education | 1 | 2022 | 226 | 0.050 |
Why?
|
Phenylalanine | 2 | 2002 | 367 | 0.050 |
Why?
|
Menstrual Cycle | 1 | 2004 | 546 | 0.050 |
Why?
|
Visual Pathways | 1 | 2005 | 557 | 0.050 |
Why?
|
Social Support | 2 | 2008 | 2193 | 0.040 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 362 | 0.040 |
Why?
|
Pentylenetetrazole | 1 | 2000 | 72 | 0.040 |
Why?
|
Acoustic Stimulation | 2 | 2021 | 1255 | 0.040 |
Why?
|
Contractile Proteins | 1 | 2001 | 240 | 0.040 |
Why?
|
Child | 10 | 2022 | 80917 | 0.040 |
Why?
|
North America | 1 | 2003 | 1289 | 0.040 |
Why?
|
Denervation | 1 | 2000 | 265 | 0.040 |
Why?
|
Sweetening Agents | 1 | 2002 | 290 | 0.040 |
Why?
|
Extracellular Space | 1 | 2021 | 563 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2011 | 65371 | 0.040 |
Why?
|
Androgens | 1 | 2006 | 1281 | 0.040 |
Why?
|
Image Enhancement | 2 | 2000 | 2880 | 0.040 |
Why?
|
Cerebral Ventricles | 1 | 2001 | 550 | 0.040 |
Why?
|
Pons | 1 | 2000 | 242 | 0.040 |
Why?
|
Medulla Oblongata | 1 | 2000 | 248 | 0.040 |
Why?
|
Boston | 2 | 2008 | 9374 | 0.040 |
Why?
|
Gyrus Cinguli | 1 | 2005 | 1135 | 0.040 |
Why?
|
Death, Sudden | 1 | 2000 | 301 | 0.040 |
Why?
|
Attitude to Health | 2 | 2004 | 2025 | 0.040 |
Why?
|
X Chromosome | 1 | 2001 | 819 | 0.040 |
Why?
|
Apraxias | 1 | 1998 | 58 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2009 | 14783 | 0.040 |
Why?
|
Synapses | 1 | 2007 | 1765 | 0.040 |
Why?
|
Decision Making | 2 | 2008 | 3953 | 0.040 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2000 | 270 | 0.040 |
Why?
|
Somatosensory Cortex | 1 | 2021 | 516 | 0.040 |
Why?
|
Oximetry | 1 | 2000 | 462 | 0.030 |
Why?
|
Respiration Disorders | 1 | 2000 | 364 | 0.030 |
Why?
|
Rats | 4 | 2000 | 23760 | 0.030 |
Why?
|
Life Style | 1 | 2008 | 3932 | 0.030 |
Why?
|
Odds Ratio | 1 | 2009 | 9669 | 0.030 |
Why?
|
Form Perception | 1 | 1997 | 175 | 0.030 |
Why?
|
Linear Models | 3 | 2013 | 5884 | 0.030 |
Why?
|
Double-Blind Method | 3 | 2010 | 12465 | 0.030 |
Why?
|
Cricetinae | 1 | 2000 | 2423 | 0.030 |
Why?
|
Psychological Tests | 1 | 1998 | 643 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2001 | 1133 | 0.030 |
Why?
|
Writing | 1 | 1998 | 200 | 0.030 |
Why?
|
Locus Coeruleus | 1 | 1998 | 243 | 0.030 |
Why?
|
Neurologic Examination | 2 | 1993 | 914 | 0.030 |
Why?
|
Postoperative Complications | 3 | 2009 | 15832 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1999 | 2300 | 0.030 |
Why?
|
Attention | 3 | 2006 | 2424 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2010 | 9015 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2363 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2008 | 3533 | 0.030 |
Why?
|
Sexual Behavior | 1 | 2004 | 2197 | 0.030 |
Why?
|
Amobarbital | 2 | 1991 | 43 | 0.030 |
Why?
|
Abnormalities, Multiple | 1 | 2001 | 1424 | 0.030 |
Why?
|
Outpatients | 1 | 2002 | 1600 | 0.030 |
Why?
|
Pulmonary Fibrosis | 1 | 1998 | 506 | 0.030 |
Why?
|
Endocrine System Diseases | 2 | 1986 | 250 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2000 | 1793 | 0.030 |
Why?
|
Encephalitis | 1 | 1997 | 441 | 0.030 |
Why?
|
Nerve Net | 1 | 2006 | 2352 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2010 | 15948 | 0.030 |
Why?
|
Motor Activity | 2 | 2020 | 2711 | 0.030 |
Why?
|
Sphenoid Sinus | 1 | 1993 | 101 | 0.030 |
Why?
|
Clonazepam | 1 | 1993 | 135 | 0.030 |
Why?
|
Choice Behavior | 2 | 2011 | 848 | 0.030 |
Why?
|
Electric Stimulation Therapy | 2 | 2009 | 635 | 0.030 |
Why?
|
Skull | 2 | 2010 | 820 | 0.030 |
Why?
|
Cerebrovascular Disorders | 1 | 1999 | 1485 | 0.030 |
Why?
|
Cues | 2 | 2010 | 878 | 0.030 |
Why?
|
Encephalitis, Tick-Borne | 1 | 1993 | 45 | 0.030 |
Why?
|
Amnesia | 1 | 1994 | 257 | 0.020 |
Why?
|
Affect | 2 | 2002 | 1495 | 0.020 |
Why?
|
Animals | 8 | 2021 | 169246 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 1998 | 2107 | 0.020 |
Why?
|
Secretory Rate | 1 | 1991 | 82 | 0.020 |
Why?
|
Equipment Design | 1 | 2000 | 3522 | 0.020 |
Why?
|
Dendrites | 1 | 1994 | 472 | 0.020 |
Why?
|
Aphasia, Broca | 1 | 1991 | 52 | 0.020 |
Why?
|
Entropy | 1 | 2012 | 211 | 0.020 |
Why?
|
UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2011 | 68 | 0.020 |
Why?
|
Software | 2 | 2017 | 4478 | 0.020 |
Why?
|
Neurofibromatosis 1 | 1 | 1996 | 561 | 0.020 |
Why?
|
Aphasia | 1 | 1993 | 193 | 0.020 |
Why?
|
Aromatase | 1 | 1991 | 147 | 0.020 |
Why?
|
Wakefulness | 1 | 2018 | 1284 | 0.020 |
Why?
|
Incidence | 1 | 2008 | 21538 | 0.020 |
Why?
|
Electrocardiography | 2 | 2000 | 6412 | 0.020 |
Why?
|
Cohort Studies | 2 | 2011 | 41754 | 0.020 |
Why?
|
Dopamine beta-Hydroxylase | 2 | 2000 | 74 | 0.020 |
Why?
|
Engineering | 1 | 2009 | 56 | 0.020 |
Why?
|
Cerebellar Neoplasms | 1 | 1994 | 591 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2003 | 3231 | 0.020 |
Why?
|
Demography | 2 | 2004 | 1641 | 0.020 |
Why?
|
Electric Conductivity | 1 | 2010 | 407 | 0.020 |
Why?
|
Models, Neurological | 2 | 2010 | 1776 | 0.020 |
Why?
|
Medulloblastoma | 1 | 1994 | 683 | 0.020 |
Why?
|
Theft | 1 | 1988 | 20 | 0.020 |
Why?
|
Tomography, Optical | 1 | 2009 | 129 | 0.020 |
Why?
|
Dehydroepiandrosterone | 2 | 2006 | 259 | 0.020 |
Why?
|
Organ Specificity | 1 | 1993 | 1968 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2010 | 556 | 0.020 |
Why?
|
Neurotoxins | 1 | 2009 | 240 | 0.020 |
Why?
|
Precipitating Factors | 1 | 2008 | 51 | 0.020 |
Why?
|
Lung Transplantation | 1 | 1998 | 1309 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 1999 | 11095 | 0.020 |
Why?
|
Epilepsy, Reflex | 1 | 2008 | 25 | 0.020 |
Why?
|
Georgia | 1 | 2008 | 186 | 0.020 |
Why?
|
Polysomnography | 1 | 1995 | 1871 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 1994 | 806 | 0.020 |
Why?
|
Heart Rate | 1 | 1999 | 4214 | 0.020 |
Why?
|
Cerebral Infarction | 1 | 1993 | 969 | 0.020 |
Why?
|
Psychosurgery | 1 | 1988 | 86 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2010 | 441 | 0.020 |
Why?
|
Feedback | 1 | 1991 | 799 | 0.020 |
Why?
|
Facial Expression | 1 | 1991 | 515 | 0.020 |
Why?
|
Vision, Ocular | 1 | 1990 | 458 | 0.020 |
Why?
|
Androstanes | 1 | 2006 | 20 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 1995 | 4860 | 0.020 |
Why?
|
Cognition Disorders | 2 | 2003 | 3980 | 0.020 |
Why?
|
Administration, Oral | 1 | 1995 | 4030 | 0.020 |
Why?
|
Ambulatory Care | 1 | 1998 | 2783 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 2010 | 540 | 0.020 |
Why?
|
Nurse's Role | 1 | 2008 | 188 | 0.020 |
Why?
|
Neonatal Screening | 1 | 2011 | 620 | 0.020 |
Why?
|
Education | 1 | 2009 | 533 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1998 | 10760 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2006 | 455 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 30256 | 0.020 |
Why?
|
Brain Neoplasms | 3 | 2016 | 9118 | 0.020 |
Why?
|
Biological Availability | 1 | 2006 | 389 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 1988 | 553 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1995 | 6029 | 0.020 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2006 | 193 | 0.010 |
Why?
|
Radiography | 2 | 1993 | 6983 | 0.010 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2009 | 752 | 0.010 |
Why?
|
Blood Glucose | 1 | 1998 | 6430 | 0.010 |
Why?
|
Photic Stimulation | 2 | 2003 | 1997 | 0.010 |
Why?
|
Drug Resistance | 1 | 2009 | 1599 | 0.010 |
Why?
|
Muscles | 1 | 1988 | 1582 | 0.010 |
Why?
|
Internal-External Control | 1 | 2004 | 348 | 0.010 |
Why?
|
Orientation | 1 | 2005 | 320 | 0.010 |
Why?
|
Electromyography | 1 | 1988 | 1401 | 0.010 |
Why?
|
Corpus Callosum | 1 | 1988 | 753 | 0.010 |
Why?
|
Neurosurgery | 1 | 2009 | 682 | 0.010 |
Why?
|
Visual Field Tests | 1 | 2005 | 415 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22379 | 0.010 |
Why?
|
Memory, Short-Term | 1 | 2009 | 1008 | 0.010 |
Why?
|
Judgment | 1 | 2005 | 273 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22291 | 0.010 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2004 | 277 | 0.010 |
Why?
|
Neurodegenerative Diseases | 1 | 2011 | 1095 | 0.010 |
Why?
|
Pilot Projects | 1 | 1995 | 8741 | 0.010 |
Why?
|
Methanol | 1 | 2002 | 91 | 0.010 |
Why?
|
Survival Analysis | 1 | 1994 | 10101 | 0.010 |
Why?
|
Personal Satisfaction | 1 | 2006 | 643 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2001 | 325 | 0.010 |
Why?
|
Glioma | 1 | 2016 | 3503 | 0.010 |
Why?
|
Nonlinear Dynamics | 1 | 2004 | 493 | 0.010 |
Why?
|
Endocrine System | 1 | 2002 | 113 | 0.010 |
Why?
|
Risk Factors | 1 | 2008 | 74944 | 0.010 |
Why?
|
Neural Inhibition | 1 | 2005 | 588 | 0.010 |
Why?
|
Receptors, Catecholamine | 1 | 2000 | 6 | 0.010 |
Why?
|
Phenylethanolamine N-Methyltransferase | 1 | 2000 | 18 | 0.010 |
Why?
|
Polycystic Ovary Syndrome | 1 | 1984 | 383 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 2709 | 0.010 |
Why?
|
Employment | 1 | 2006 | 1110 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2006 | 1177 | 0.010 |
Why?
|
Goals | 1 | 2004 | 717 | 0.010 |
Why?
|
Oscillometry | 1 | 1999 | 151 | 0.010 |
Why?
|
Emotions | 1 | 1991 | 2767 | 0.010 |
Why?
|
Phenotype | 2 | 2011 | 16726 | 0.010 |
Why?
|
Neural Pathways | 1 | 2010 | 3117 | 0.010 |
Why?
|
Visual Fields | 1 | 2005 | 1065 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 2937 | 0.010 |
Why?
|
Visual Cortex | 1 | 2006 | 1094 | 0.010 |
Why?
|
Prospective Studies | 3 | 2010 | 54926 | 0.010 |
Why?
|
Kainic Acid | 1 | 1998 | 203 | 0.010 |
Why?
|
Pediatrics | 1 | 2013 | 3629 | 0.010 |
Why?
|
Nanoparticles | 1 | 2009 | 1985 | 0.010 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2002 | 465 | 0.010 |
Why?
|
DNA Primers | 1 | 2001 | 2828 | 0.010 |
Why?
|
Observer Variation | 1 | 2003 | 2622 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2002 | 1338 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 13045 | 0.010 |
Why?
|
Diencephalon | 1 | 1996 | 54 | 0.010 |
Why?
|
Program Evaluation | 1 | 2004 | 2507 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10632 | 0.010 |
Why?
|
Aging | 2 | 2005 | 8744 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2337 | 0.010 |
Why?
|
Mice | 1 | 2021 | 82029 | 0.010 |
Why?
|
Disease Progression | 1 | 2011 | 13671 | 0.010 |
Why?
|
Headache | 1 | 2002 | 1263 | 0.010 |
Why?
|
Follicle Stimulating Hormone | 2 | 1986 | 727 | 0.010 |
Why?
|
Regression Analysis | 1 | 2003 | 6340 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 42669 | 0.010 |
Why?
|
Drug Hypersensitivity | 1 | 2002 | 923 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2001 | 4120 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2008 | 4530 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 1988 | 20760 | 0.010 |
Why?
|
Atrophy | 1 | 1997 | 1646 | 0.010 |
Why?
|
Myelin Sheath | 1 | 1996 | 652 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2004 | 3488 | 0.010 |
Why?
|
Brain Injuries | 1 | 2004 | 2057 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 26422 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2001 | 2650 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2004 | 7852 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 1990 | 181 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1994 | 1500 | 0.010 |
Why?
|
Weight Loss | 1 | 2002 | 2721 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 1994 | 1375 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1994 | 1081 | 0.010 |
Why?
|
Pulsatile Flow | 1 | 1990 | 320 | 0.010 |
Why?
|
Antigens | 1 | 1994 | 1442 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1993 | 12252 | 0.000 |
Why?
|
Drug Tolerance | 1 | 1989 | 365 | 0.000 |
Why?
|
Blotting, Western | 1 | 1994 | 5027 | 0.000 |
Why?
|
Videotape Recording | 1 | 1988 | 335 | 0.000 |
Why?
|
Depression | 1 | 2006 | 8230 | 0.000 |
Why?
|
Axons | 1 | 1994 | 1677 | 0.000 |
Why?
|
Carotid Arteries | 1 | 1990 | 942 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1989 | 1534 | 0.000 |
Why?
|
Autoantibodies | 1 | 1994 | 2121 | 0.000 |
Why?
|
Ovarian Cysts | 1 | 1986 | 108 | 0.000 |
Why?
|
Hyperprolactinemia | 1 | 1986 | 124 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2005 | 26379 | 0.000 |
Why?
|
Prolactin | 1 | 1986 | 627 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2013 | 81762 | 0.000 |
Why?
|
Erectile Dysfunction | 1 | 1986 | 437 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1994 | 8542 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2003 | 39348 | 0.000 |
Why?
|
Hypothalamus | 1 | 1984 | 1004 | 0.000 |
Why?
|